Do You Need a License to Sell Peptides in Tennessee?

There is no single permit called a "peptide license" — not in Tennessee, not anywhere. What a business actually needs depends on three separate questions that buyers routinely collapse into one: whether you need general business registration to sell goods at all, whether the products you carry fall under drug distribution regulation enforced through pharmacy and supply-chain rules, and whether your catalog and your marketing stay inside the research-use-only lane. The first has a routine answer your accountant or county clerk can walk you through. The second and third are questions for a licensed attorney in your state, and how you answer them changes everything downstream. This article describes the general framework and the questions worth asking — it is informational, and it is not legal advice.

The question that is actually three questions

When an operator asks whether they need a license, they are usually asking one of three very different things without realizing it.

The first is commercial: am I allowed to run a business that sells physical products? That is a registration question, and it looks the same whether you sell research compounds, coffee, or fasteners.

The second is categorical: is what I'm selling regulated as a drug, and does moving it through my hands make me a distributor? This is where the real exposure sits. The answer does not depend only on the molecule — it depends heavily on how the product is described, who it is sold to, and what it is represented as being for.

The third is operational: does my business actually behave like a research supplier, or does it behave like something else while using research language as cover? Regulators and payment processors have both gotten better at telling the difference.

Most of the confusion in this market comes from answering question one and assuming questions two and three came along with it. They did not.

Registration is the floor, not the ceiling

Generally, a business selling goods needs a legal entity, registration with the state, and a sales tax account. In most states, that means forming an LLC or corporation, registering with the state revenue department, obtaining a sales tax permit, and in many jurisdictions filing for a local business license at the county or municipal level. Requirements and thresholds vary by state and even by county, so confirm the current ones with your state revenue department and county clerk's office rather than relying on a summary written for a national audience.

One piece of that stack matters specifically to wholesale buyers: the resale certificate. If you are purchasing inventory to resell, most states let you buy without paying sales tax at the point of purchase, provided you furnish a valid resale or exemption certificate to the supplier. Any serious wholesale program will ask for it during onboarding. If a supplier never asks for one and never asks what your business is, that tells you something about how they handle compliance generally.

None of this registration work answers the harder question. A sales tax permit does not authorize you to distribute a regulated drug product, and no state clerk is going to review your catalog when they issue it. Registration proves you exist as a business. It does not classify what you sell.

Where drug distribution rules enter the picture

Federal law regulates prescription drugs through a licensed, traceable supply chain, and states layer their own wholesale distributor licensing on top of it — typically administered through the state board of pharmacy. If a product is a drug, the people who buy, hold, and resell it generally need to be licensed for that role, and the paperwork obligations that come with it are substantial.

So the operative question is not "do peptides need a license." It is: is the specific product I want to carry treated as a drug in the channel I want to sell it through, and does my role make me a distributor? That is a legal determination, and it is fact-specific. Bring these to your attorney rather than to a forum:

• Is this compound an approved drug product, a component of one, or neither — and does the answer change depending on how it is labeled and sold?
• Do my marketing claims, product pages, or sales conversations represent the product as intended for use in people? Intended use has historically been inferred from how a product is promoted, not just from what is printed on the vial.
• Am I taking title and physical possession, or acting as an agent? Does that distinction matter under my state's wholesale distributor rules?
• Who are my customers — licensed businesses, research institutions, or the general public? Does selling to one category pull me into licensing that another would not?
• What recordkeeping would I need to produce if a state board asked tomorrow?

Notice that none of these are answered with a yes or a no here. Anyone who tells you flatly that a state "allows" or "prohibits" peptide resale, without looking at your catalog and your customer base, is guessing on your behalf. Some widely discussed compounds are approved pharmaceutical products subject to an entirely different regulatory regime and simply do not belong in a research catalog at all — knowing which is which is part of the diligence.

Research use only is a discipline, not a disclaimer

The research-use-only lane is real, and it is also the easiest thing in this industry to do badly. A disclaimer in six-point type at the bottom of a page does not create RUO status if everything above it is written to sell a human outcome.

Operating credibly in this lane means the whole business is consistent. Product pages describe the compound and what the literature examines — research suggests, studies indicate — never what a person should expect. There is no dosing guidance, no administration instructions, no reconstitution walkthroughs, no before-and-after imagery. Supplies are not bundled with compounds in a way that assembles an implied human-use kit. Customer service answers questions about specifications, purity, and documentation, and declines the ones that are really requests for medical guidance.

It also means knowing your buyer. Qualifying accounts, keeping records of who you sold what to, and declining orders that arrive with human-use questions attached are all part of the same discipline. This is where a lot of resellers quietly fail: the catalog is compliant and the sales emails are not.

For a reseller building a brand, this is the part worth investing in early, because it is much harder to unwind later. Your supplier's documentation supports it. Your own marketing has to carry it.

Sorting the three lanes before you stock anything

If you cannot fill in the middle row confidently, that is the row to resolve before placing a first order — not after inventory is sitting on your shelf.

What to verify in a supplier before your name is on the invoice

Once the legal side is with counsel, the sourcing side is yours. The reseller's name is on the invoice and the packing slip, which means supplier problems become your problems.

Ask for a certificate of analysis tied to the specific batch you will receive — not a generic sample COA, not a document from a batch two years old. Ask whether purity is established by HPLC and identity confirmed independently. Ask what else is screened for beyond purity, since identity and purity alone say nothing about contamination.

Then watch for the patterns that should end a conversation early. Pricing that only appears after you hand over contact details and sit through a sales call. COAs offered as a paid add-on, or produced only on request for a specific customer. Test reports with no lab attribution, no batch number, and no way to check them independently. Fulfillment that ships from an origin the supplier will not name, or timelines that get vaguer the more specifically you ask. Each of these is a supplier deciding that opacity is cheaper than documentation — and you inherit that decision.

What Real Peptides does differently

Real Peptides supplies research-use-only compounds to business buyers through its Wholesale Partner Program, and the documentation is built to be checked rather than described.

Every batch is tested to 99%+ HPLC purity and put through six-panel batch testing covering identity, purity, and contamination screening. The resulting COAs are publicly verifiable — a prospective partner can look at the lab results before applying, rather than requesting them after an order, paying extra for them, or taking a claimed number on faith. That distinction matters when a customer of yours asks where the numbers came from.

Fulfillment is US-based, with orders shipping in 5–7 days, so inventory planning does not depend on an overseas customs queue. The wholesale application itself is a three-step process built around qualifying the business account, which is also where documentation like your resale certificate is handled.

What Real Peptides does not do is tell you whether your business model is lawful in your state. No supplier can. What a supplier can do is give you a catalog with verifiable specifications and documentation you can hand to your own counsel without embarrassment.

If the legal questions above are already with your attorney and you are choosing a sourcing partner, the Wholesale Partner Program application is the next step — it qualifies the account, sets up tax documentation, and gives you access to tier pricing without a discovery call standing between you and a number.

More detail on program mechanics is available on the wholesale peptides program page, the licensing overview at do you need a license to sell peptides covers the general framework in more depth, and qualified businesses can apply for a wholesale account directly.